MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Meregaglia et al. explored the expected impact of implementing the EU HTA Regulation and Joint Clinical Assessment through a multi-stakeholder case study in Italy.

On May 20, 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) announced that the MHRA-NICE Real-World Evidence Scientific Dialogue (RWE SD) pilot has become an established service. The service will be delivered through precompetitive “safe harbour” workshops jointly convened by the MHRA and the National Institute for Health and Care Excellence (NICE). Four workshops will be held each year, organized across two application cycles. Expressions of interest for the first 2026 cycle may be submitted until August 17, 2026.

On June 12, 2026, the Bundestag held its first reading of the planned financial reform of the statutory health insurance system (GKV). The German Federal Government has proposed a comprehensive reform package to address the severe financial deficit in the GKV.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Pisavadia et al. examined the economic value of clinical registries through a systematic scoping review of economic evaluations, costing studies, and grey literature.

As of June 2026, the HTA Center of the Västra Götaland Region in Sweden is conducting six health technology assessments across areas such as gynecology, orthopedics, neurology, and in-vitro diagnostics.

On June 3, 2026, the submission period opened for Joint Scientific Consultation (JSC) requests under the EU Health Technology Assessment Regulation (HTAR) framework. The deadline for submitting requests is July 1, 2026. JSCs offer health technology developers the opportunity to seek scientific advice on the information and evidence required for a potential future EU Joint Clinical Assessment.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of June 15th, we plan to work on 18 projects. Review the complete list of planned activities in this post.

The MTRC team has co-authored a new health economic publication on diagnostic strategies for suspected community-acquired pneumonia in adults. The paper evaluates the clinical and economic consequences of adding MeMed BV to standard of care in emergency departments in France and Spain.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Haon et al. mapped early and accelerated access pathways for medical devices across the 27 EU Member States to clarify how patients may receive devices before full routine market access in situations of unmet need.

Between January 1 and June 1, 2026, seven MedTech-related mini-HTAs were initiated in Norway across orthopedics, neurology and rehabilitation, in vitro diagnostics, interventional radiology, diagnostic imaging, and e-health. These assessments are conducted as part of Norway’s framework for the managed introduction of innovations, known as “New Methods”.

MTRC is pleased to announce the publication of Gateway to Europe: The Definitive Guide to Medical Device Market Access by Oleg Borisenko, MD, PhD. Drawing on more than 1,000 European market access projects, this one-of-a-kind book provides a practical guide to reimbursement, HTA, payer approval, evidence requirements, and country-specific access pathways for medical devices, IVDs, and selected digital health technologies.

The application window for changes in the Swiss Classification of Surgical Procedures (CHOP) is open from June 1 to September 14, 2026. The application window for changes in the SwissDRG system is open from June 1 to July 13, 2026. The eligible applicants in both processes are limited to system stakeholders.